Table of Contents

Articles

• You have access

  Heterologous Expression of Human Drug-metabolizing Enzymes

  F. Peter Guengerich, Asit Parikh, Eric F. Johnson, Toby H. Richardson, Claes von Wachenfeldt, Jose Cosme, Frank Jung, Christian P. Strassburg, Michael P. Manns, Robert H. Tukey, Mike Pritchard, Sylvie Fournel-Gigleux and Brian Burchell

  Drug Metabolism and Disposition November 1997, 25 (11) 1234-1241;
• You have access

  Inactivation of Cytochrome P450s 2B1, 2B4, 2B6, and 2B11 by Arylalkynes

  Elizabeth S. Roberts, Nancy Eddy Hopkins, Maryam Foroozesh, William L. Alworth, James R. Halpert and Paul F. Hollenberg

  Drug Metabolism and Disposition November 1997, 25 (11) 1242-1248;
• You have access

  Gender, Age and Dose Effects of Neonatally Administered Aspartate on the Sexually Dimorphic Plasma Growth Hormone Profiles Regulating Expression of the Rat Sex-Dependent Hepatic CYP Isoforms

  Arun K. Agrawal and Bernard H. Shapiro

  Drug Metabolism and Disposition November 1997, 25 (11) 1249-1256;
• You have access

  ¹⁴C-Propoxyphene Demethylation in the Rat

  Yves Horsmans, Alain Saliez, Véronique Van Den Berge, Jean-Pierre Desager, André P. Geubel, Stanislas Pauwels and Luc Lambotte

  Drug Metabolism and Disposition November 1997, 25 (11) 1257-1259;
• You have access

  Use of the Deconvolution Principle in the Estimation of Absorption and Pre-systemic Intestinal Elimination of Drugs

  Yazdi K. Pithavala, Inmaculada Soria and Cheryl L. Zimmerman

  Drug Metabolism and Disposition November 1997, 25 (11) 1260-1265;
• You have access

  Formation of Guanoxabenz from Guanabenz in Human Liver

  Bernd Clement and Mark Demesmaeker

  Drug Metabolism and Disposition November 1997, 25 (11) 1266-1271;
• You have access

  Pharmacokinetics and Metabolism in Mice of a Phosphorothioate Oligonucleotide Antisense Inhibitor of C-raf-1 Kinase Expression

  Richard S. Geary, Janet M. Leeds, Jon Fitchett, Todd Burckin, Loanne Truong, Charles Spainhour, Moire Creek and Arthur A. Levin

  Drug Metabolism and Disposition November 1997, 25 (11) 1272-1281;
• You have access

  Metabolic Profiles of Montelukast Sodium (Singulair), a Potent Cysteinyl Leukotriene₁ Receptor Antagonist, in Human Plasma and Bile

  S. K. Balani, X. Xu, V. Pratha, M. A. Koss, R. D. Amin, C. Dufresne, R. R. Miller, B. H. Arison, G. A. Doss, M. Chiba, A. Freeman, S. D. Holland, J. I. Schwartz, K. C. Lasseter, B. J. Gertz, J. I. Isenberg, J. D. Rogers, J. H. Lin and T. A. Baillie

  Drug Metabolism and Disposition November 1997, 25 (11) 1282-1287;
• You have access

  Metabolism and Excretion of a Novel Antianxiety Drug Candidate, CP-93,393, in Long Evans Rats

  Chandra Prakash and Victor Soliman

  Drug Metabolism and Disposition November 1997, 25 (11) 1288-1297;
• You have access

  Metabolism of the Antiandrogenic Drug (Flutamide) by Human CYP1A2

  Manjunath S. Shet, Michael McPhaul, Charles W. Fisher, Nancy R. Stallings and Ronald W. Estabrook

  Drug Metabolism and Disposition November 1997, 25 (11) 1298-1303;
• You have access

  Studies on the Interactions of Chiral Secondary Alcohols with Rat Hydroxysteroid Sulfotransferase STa

  Erden Banoglu and Michael W. Duffel

  Drug Metabolism and Disposition November 1997, 25 (11) 1304-1310;
• You have access

  Reversible Formation of Fatty Acid Esters of Budesonide, an Antiasthma Glucocorticoid, in Human Lung and Liver Microsomes

  Anders Tunek, Karin Sjödin and Gösta Hallström

  Drug Metabolism and Disposition November 1997, 25 (11) 1311-1317;
• You have access

  Synthesis and Reactivity of Coumarin 3,4-Epoxide

  Stephanie L. Born, Pedro A. Rodriguez, Cynthia L. Eddy and Lois D. Lehman-McKeeman

  Drug Metabolism and Disposition November 1997, 25 (11) 1318-1324;